Sun Pharmaceutical reports 75% fall in Q3 consolidated net profit

14 Feb 2018 Evaluate

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2017.

The company has reported net profit of Rs 40.50 crore for the quarter under review as against net loss of Rs 158.34 crore for the same quarter in the previous year. Total income of the company increased by 2.51% to Rs 2078.70 crore for Q3FY18 as compared Rs 2027.72 crore for the corresponding quarter previous year. 

On consolidate basis, the company has reported 75.17% fall in its net profit after taxes, share of profit of associates and joint ventures and non-controlling interest at Rs 365.39 crore for the quarter ended December 31, 2017 as compared to Rs 1,471.82 crore for the corresponding quarter in the FY17. Total consolidated income of the company decreased by 15.72% at Rs 6782.42 crore for quarter under review as compared to Rs 8047.26 crore for the same quarter ended previous year.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×